1. Aboulker, P., Soulier, J. P., Larrieu, M. J.: Syndrome hémorrhagique avec fibrinolyse associé au cancer de la prostate. Presse méd. 1, 353 (1955).
2. Alkjaersig, N., Fletcher, A. P., Sherry, S.: Pathogenesis of the coagulation defect developing during plasma proteolytic (fibrinolytic) states. II. The significance, mechanism and consequence of defective fibrin polymerization. J. clin. Invest. 41, 917 (1962).
3. Amundsen, M. A., Spittel, J. A., Jr., Thompson, J. H., Jr., Owen, C. A.: Hyper-coagulability associated with malignant disease and with the post-operative state. Evidence for elevated levels of antihemophilic globulin. Ann. Intern. Med. 58, 608 (1963).
4. Andersson, L.: Fibrinolysis in patients with prostatic cancer. Acta chir. scand. 126, 172 (1963).
5. Andersson, L., Nilsson, I. M.: Effect of e-amino-n-caproic acid (r-ACA) on fibrinolysis and bleeding conditions in prostatic disease. Acta chir. scand. 121, 291 (1961).